• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

撤回:肥胖悖论与心血管疾病。

WITHDRAWN: Obesity Paradox and Cardiovascular Diseases.

作者信息

Ganna Isayeva, Anna Shalimova

机构信息

Department of Complex Risk Reduction of Chronic Non-communicable Diseases, L.T. Mala National Therapy Institute of National Academy of Medical Science of Ukraine

出版信息

Curr Cardiol Rev. 2022 May 14. doi: 10.2174/1573403X18666220514150051.

DOI:10.2174/1573403X18666220514150051
PMID:35570515
Abstract

UNLABELLED

Since the authors are not responding to the editor’s requests to fulfill the editorial requirement, therefore, the article has been withdrawn. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php.

BENTHAM SCIENCE DISCLAIMER

It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.

摘要

未标注

由于作者未回应编辑满足编辑要求的请求,因此,该文章已被撤回。本瑟姆科学出版社就可能给该期刊读者带来的不便表示歉意。关于文章撤回的本瑟姆科学出版社编辑政策可在https://benthamscience.com/editorial-policies-main.php查看。

本瑟姆科学出版社免责声明

投稿至本期刊的稿件未在其他地方发表且不会同时在其他地方提交或发表,这是发表的条件。此外,已在其他地方发表的任何数据、插图、结构或表格必须注明出处,且必须获得复制的版权许可。严禁抄袭,提交文章以供发表即表示作者同意,如果发现抄袭或虚假信息,出版商有权对作者采取适当行动。提交稿件即表示作者同意,若文章被接受发表,其文章版权将转让给出版商。

相似文献

1
WITHDRAWN: Obesity Paradox and Cardiovascular Diseases.撤回:肥胖悖论与心血管疾病。
Curr Cardiol Rev. 2022 May 14. doi: 10.2174/1573403X18666220514150051.
2
WITHDRAWN: Computational Chemistry in the Fight Against SARSCoV-2.撤回:计算化学在抗击新冠病毒中的应用
Comb Chem High Throughput Screen. 2022 Jan 11. doi: 10.2174/1386207325666220111112656.
3
WITHDRAWN: Main Diagnostic Methods for COVID-19: Integrative Review.撤回:新型冠状病毒肺炎的主要诊断方法:综合综述
Curr Pharm Des. 2022 May 26. doi: 10.2174/1381612828666220526113232.
4
WITHDRAWN: Therapeutic Targeted Approaches for Covid-19 Treatment.撤回:新冠病毒病治疗的靶向治疗方法
Curr Pharm Biotechnol. 2022 Mar 4. doi: 10.2174/1389201023666220304163903.
5
WITHDRAWN: Conjugation of Ruthenium Drugs to Nanocellulose using Boronic Ester.撤回:使用硼酸酯将钌药物与纳米纤维素共轭
Curr Drug Deliv. 2023 Feb 16. doi: 10.2174/1567201820666230216110631.
6
WITHDRAWN: Recent Advances of Nanotechnology in the Treatment of Skin Cancer.撤回:纳米技术在皮肤癌治疗中的最新进展。
Curr Pharm Biotechnol. 2022 Apr 4. doi: 10.2174/1389201023666220404113242.
7
WITHDRAWN: Moderna’s COVID 19 Patent Under the Magnifying Glass.撤回:放大镜下的莫德纳新冠专利。
Recent Pat Biotechnol. 2022 Jun 16. doi: 10.2174/1872208316666220616110516.
8
WITHDRAWN: Recent Advances and Reports on Encapsulation in the Food Matrix: A Review.撤回:食品基质中包封的最新进展与报告:综述
Curr Pharm Biotechnol. 2022 May 13. doi: 10.2174/1389201023666220513105654.
9
WITHDRAWN: Scrutinizing the Role of Genetically Modified Herbs (GMHs) in the Treatment of Various Diseases.
Recent Pat Biotechnol. 2022 May 12. doi: 10.2174/1872208316666220512113921.
10
WITHDRAWN: Comparing Nucleated Red Blood Cells in Neonates with and without Retinopathy.撤回:比较患有和未患视网膜病变的新生儿中的有核红细胞。
Curr Pediatr Rev. 2021 Sep 9. doi: 10.2174/1573396317666210909155024.

引用本文的文献

1
Life-course obesity and heart failure: a two-sample Mendelian randomization study.生命历程中的肥胖与心力衰竭:一项双样本孟德尔随机化研究。
Intern Emerg Med. 2025 Jan;20(1):171-180. doi: 10.1007/s11739-024-03772-8. Epub 2024 Sep 24.
2
Advantages of DES over BMS in Preventing the Risk of Myocardial Infarction, Ischemic Stroke, and Mortality in Various Populations.药物洗脱支架(DES)相较于裸金属支架(BMS)在预防不同人群中心肌梗死、缺血性中风和死亡风险方面的优势。
J Clin Med. 2022 Dec 20;12(1):24. doi: 10.3390/jcm12010024.
3
Potential therapeutic effects and pharmacological evidence of sinomenine in central nervous system disorders.
青藤碱在中枢神经系统疾病中的潜在治疗作用及药理学证据。
Front Pharmacol. 2022 Sep 16;13:1015035. doi: 10.3389/fphar.2022.1015035. eCollection 2022.